These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients. Madsbad S; Krarup T; Faber OK; Binder C; Regeur L Diabetologia; 1982 Jan; 22(1):16-20. PubMed ID: 7037505 [TBL] [Abstract][Full Text] [Related]
24. Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells. Horwitz DL Horm Metab Res Suppl; 1979; (8):68-71. PubMed ID: 395093 [TBL] [Abstract][Full Text] [Related]
25. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus]. Starostina EG; Lobanova AM; Magomedova AK Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782 [TBL] [Abstract][Full Text] [Related]
26. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Glaser B; Leibovich G; Nesher R; Hartling S; Binder C; Cerasi E Acta Endocrinol (Copenh); 1988 Jul; 118(3):365-73. PubMed ID: 3293339 [TBL] [Abstract][Full Text] [Related]
27. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects. Otim MA East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922 [No Abstract] [Full Text] [Related]
28. Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes. Madsbad S Diabetologia; 1983 Mar; 24(3):141-7. PubMed ID: 6341142 [No Abstract] [Full Text] [Related]
29. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
30. Beta-cell function and metabolic control in insulin treated diabetics. Madsbad S; McNair P; Faber OK; Binder C; Christiansen C; Transbøl I Acta Endocrinol (Copenh); 1980 Feb; 93(2):196-200. PubMed ID: 6990673 [TBL] [Abstract][Full Text] [Related]
31. Residual beta-cell function in type II diabetes and evaluation of the hepatic insulin extraction. Toledo e Souza IT; Wajchenberg BL; Prestes Cesar F; Almeida Neto JS Horm Metab Res; 1983 Dec; 15(12):575-80. PubMed ID: 6363239 [TBL] [Abstract][Full Text] [Related]
32. Is type 2 diabetes a different disease in obese and nonobese patients? Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Madsbad S; Faber OK; Binder C; McNair P; Christiansen C; Transbøl I Diabetes; 1978; 27 Suppl 1():262-4. PubMed ID: 344117 [TBL] [Abstract][Full Text] [Related]
34. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512 [TBL] [Abstract][Full Text] [Related]
35. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA J Clin Endocrinol Metab; 2005 Jan; 90(1):493-500. PubMed ID: 15483086 [TBL] [Abstract][Full Text] [Related]
36. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306 [TBL] [Abstract][Full Text] [Related]
37. [Functional activity of the insular apparatus of the pancreas in children with newly diagnosed diabetes mellitus]. Shcherbacheva LN; Lobanova AM; Arbuzova MI Pediatriia; 1989; (11):10-4. PubMed ID: 2691976 [TBL] [Abstract][Full Text] [Related]
38. [Determination of plasmatic C-peptide and its clinical uses]. Cautela G; Barbero PL; Gamba S; Regis G; Bruni B Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164 [TBL] [Abstract][Full Text] [Related]
39. Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring. Ahrén B; Scherstén B; Agardh CD; Lundquist I Acta Med Scand; 1981; 210(5):337-48. PubMed ID: 7039239 [No Abstract] [Full Text] [Related]
40. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. Hidaka H; Nagulesparan M; Klimes I; Clark R; Sasaki H; Aronoff SL; Vasquez B; Rubenstein AH; Unger RH J Clin Endocrinol Metab; 1982 Feb; 54(2):217-22. PubMed ID: 7033272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]